Literature DB >> 30119207

MiR-1294 confers cisplatin resistance in ovarian Cancer cells by targeting IGF1R.

Yong Zhang1, Sanxiu Huang2, Yu Guo3, Lingfeng Li4.   

Abstract

BACKGROUND: Dysregulation of miRNAs is critical for chemosensitivity to platinum-based agents in ovarian cancer (OC) which is the most aggressive gynecological cancer. However, the underlying mechanisms of miRNA-regulated platinum resistance in ovarian cancer remain unclear. In this study, we intended to investigate the effect of miR-1294 on platinum-resistant OC.
METHODS: The expression of miR-1294 in OC tissues (n = 30) and cell lines was measured by qRT-PCR. Cell transfection was carried out to establish miR-1294 overexpression or knockdown. MTT and clone formation assays were performed to examine proliferation in OC cells. Additionally, wound healing and tumor invasion assays were used to investigate cell migration and invasion, respectively. Finally, the expression of epithelial-to-mesenchymal transition (EMT)-associated proteins was measured in OC cells by western blot.
RESULTS: Our results showed that miR-1294 dysregulation manipulated OC cisplatin resistance through regulating IGF1R. Knockdown of IGF1R decreased SKOVP/DDP cell proliferation, migration, invasion and EMT. Moreover, overexpression of miR-1294 prevented OC cisplatin resistance.
CONCLUSION: Our results indicated that epigenetic regulation of IGF1R via miR-1294 was essential for cisplatin resistance in OC and provide a new avenue for OC treatment.
Copyright © 2018. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Cisplatin resistance; Epithelial-to-mesenchymal transition (EMT); Ovarian cancer (OC); Platinum-based agents; miR-1294

Mesh:

Substances:

Year:  2018        PMID: 30119207     DOI: 10.1016/j.biopha.2018.07.059

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  17 in total

Review 1.  Platinum-resistant ovarian cancer: From drug resistance mechanisms to liquid biopsy-based biomarkers for disease management.

Authors:  Mohammad Aslam Khan; Kunwar Somesh Vikramdeo; Sarabjeet Kour Sudan; Seema Singh; Annelise Wilhite; Santanu Dasgupta; Rodney Paul Rocconi; Ajay Pratap Singh
Journal:  Semin Cancer Biol       Date:  2021-08-18       Impact factor: 15.707

Review 2.  Revisiting chemoresistance in ovarian cancer: Mechanism, biomarkers, and precision medicine.

Authors:  Chong Guo; Chaoying Song; Jiali Zhang; Yisong Gao; Yuying Qi; Zongyao Zhao; Chengfu Yuan
Journal:  Genes Dis       Date:  2020-12-01

3.  KLF2-induced circZKSCAN1 potentiates the tumorigenic properties of clear cell renal cell carcinoma by targeting the miR-1294/PIM1 axis.

Authors:  Mingzi Li; Mingxun Zhang; Muling Chen; Jiantao Xiao; Xingyu Mu; Jingtao Peng; Jie Fan
Journal:  Cell Cycle       Date:  2022-03-14       Impact factor: 5.173

4.  The circ-AMOTL1/ENO1 Axis Implicated in the Tumorigenesis of OLP-Associated Oral Squamous Cell Carcinoma.

Authors:  Jin Liu; Qiaozhen Yang; Hongying Sun; Xiaxia Wang; Hexige Saiyin; Hui Zhang
Journal:  Cancer Manag Res       Date:  2020-08-12       Impact factor: 3.989

5.  Long non-coding RNA DUXAP8 promotes tumorigenesis by regulating IGF1R via miR-9-3p in hepatocellular carcinoma.

Authors:  Qiang Guan; Bo Yuan; Xiaobin Zhang; Tinghai Yan; Jiangong Li; Wuzhong Xu
Journal:  Exp Ther Med       Date:  2021-05-12       Impact factor: 2.447

6.  Identification of key genes for guiding chemotherapeutic management in ovarian cancer using translational bioinformatics.

Authors:  Danni Yuan; Haohan Zhou; Hongyu Sun; Rui Tian; Meihui Xia; Liankun Sun; Yanan Liu
Journal:  Oncol Lett       Date:  2020-05-22       Impact factor: 2.967

7.  Cisplatin decreases cyclin D2 expression via upregulating miR‑93 to inhibit lung adenocarcinoma cell growth.

Authors:  Ning Xie; Yuan-Rong Liu; Yan-Mei Li; Ya-Nan Yang; Li Pan; Yu-Bo Wei; Ping-Yu Wang; You-Jie Li; Shu-Yang Xie
Journal:  Mol Med Rep       Date:  2019-08-06       Impact factor: 2.952

8.  [MiR-300 inhibits invasion and metastasis of osteosarcoma cell MG63 by negatively regulating PTTG1].

Authors:  D Liang; X Wu; J Bai; L Zhang; C Yin; W Zhong
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-02-25

9.  Endosomal TLR-8 Senses microRNA-1294 Resulting in the Production of NFḱB Dependent Cytokines.

Authors:  Linda Pluta; Babak Yousefi; Blossom Damania; Asma A Khan
Journal:  Front Immunol       Date:  2019-12-06       Impact factor: 7.561

10.  Antitumor Effect of miR-1294/Pyruvate Kinase M2 Signaling Cascade in Osteosarcoma Cells.

Authors:  Quan Yuan; Honghao Yu; Jianhua Chen; Xiaoyu Song; Li Sun
Journal:  Onco Targets Ther       Date:  2020-02-21       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.